Giant Biogene Holding Co. Ltd.(HK:2367)
HK$20.38+0.24 (+1.19%)
HK:2367
Giant Biogene Holding Co. Ltd. financials statements
HK$20.38
At close:+0.24 (+1.19%)
Want to see HK:2367 full AI Analyst Report?
Giant Biogene Holding Co. Ltd. (2367) Income Statement
11 Followers
Giant Biogene Holding Co. Ltd. Income Statement
Last quarter (Q2 2026), Giant Biogene Holding Co. Ltd.'s total revenue was ¥2.88B, an increase of 13.26% from the same quarter last year. In Q2, Giant Biogene Holding Co. Ltd.'s net income was ¥926.74M. See Giant Biogene Holding Co. Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| ¥ 5.52B | ¥ 5.54B | ¥ 3.52B | ¥ 2.36B | ¥ 1.55B | |
| ¥ 4.43B | ¥ 4.55B | ¥ 2.95B | ¥ 2.00B | ¥ 1.35B | |
| ¥ 2.31B | ¥ 2.24B | ¥ 1.28B | ¥ 817.32M | ¥ 425.62M | |
| Depreciation and Amortization | ¥ 82.25M | ¥ 49.49M | ¥ 34.17M | ¥ 27.63M | ¥ 24.21M |
| ¥ 2.20B | ¥ 2.33B | ¥ 1.78B | ¥ 1.21B | ¥ 934.78M | |
| ¥ 2.12B | ¥ 2.31B | ¥ 1.66B | ¥ 1.13B | ¥ 914.57M | |
| ¥ 229.52M | ¥ 149.12M | ¥ 80.22M | ¥ 44.61M | ¥ 62.34M | |
| ¥ 2.35B | ¥ 2.46B | ¥ 1.75B | ¥ 1.18B | ¥ 972.92M | |
| ¥ 1.91B | ¥ 2.06B | ¥ 1.45B | ¥ 1.00B | ¥ 828.13M | |
| Per Share Metrics | |||||
| Basic EPS | ¥ 1.83 | ¥ 2.10 | ¥ 1.49 | ¥ 0.99 | ¥ 0.84 |
| Diluted EPS | ¥ 1.81 | ¥ 2.06 | ¥ 1.48 | ¥ 0.98 | ¥ 0.84 |
| Weighted Average Shares Outstanding | 1.06B | 1.00B | 980.91M | 976.00M | 974.79M |
| Weighted Average Shares Outstanding (Diluted) | 1.06B | 1.00B | 982.72M | 1.02B | 991.61M |
Currency in CNY

